E. Douglas KRAMER
5Patents
1h-index
5Co-inventors
33Inventor score
Filing activity: Mar 12, 2018 → Oct 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10617693B2 | Methods of treating and/or preventing actinic keratosis | Human Necessities | 3 | Active |
| US11497750B2 | Methods of treating and/or preventing actinic keratosis | Human Necessities | 1 | Active |
| US10849893B2 | Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer | Human Necessities | 1 | Active |
| US11752139B2 | Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer | Human Necessities | 0 | Active |
| US11389442B2 | Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.